Parunakian E - Search Results

1

Clinical and Radiologic Predictors of Response to Teprotumumab: A 3D Volumetric Analysis of 35 Patients.

Ugradar S, Parunakian E, Zimmerman E, Malkhasyan E, Raika P, Douglas RN, Kossler AL, Douglas RS. Ugradar S, et al. Among authors: parunakian e. Ophthalmic Plast Reconstr Surg. 2024 Dec 23. doi: 10.1097/IOP.0000000000002867. Online ahead of print. Ophthalmic Plast Reconstr Surg. 2024. PMID: 39714282

2

Surgical Timing for Patients with Thyroid Eye Disease Treated with Teprotumumab: A Collaborative Multicenter Study.

Walsh HL, Clauss KD, Meyer BI, Parunakian E, Yasar C, Chiou CA, Johnson TE, Ugradar S, Kossler AL, Freitag SK, Douglas RS, Wester ST. Walsh HL, et al. Among authors: parunakian e. Ophthalmic Plast Reconstr Surg. 2024 Dec 10. doi: 10.1097/IOP.0000000000002839. Online ahead of print. Ophthalmic Plast Reconstr Surg. 2024. PMID: 39656059

3

Teprotumumab for thyroid eye disease in patients with hypothyroid/euthyroid state: a multicenter case series.

Ugradar S, Parunakian E, Malkhasyan E, Raika P, Tolentino J, Kossler AL, Cockerham K, Amarikwa L, Weinberg DA, Douglas RS. Ugradar S, et al. Among authors: parunakian e. Graefes Arch Clin Exp Ophthalmol. 2024 Aug 13. doi: 10.1007/s00417-024-06599-3. Online ahead of print. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 39136754

4

The Rate of Re-treatment in Patients Treated with Teprotumumab: A Multicenter Study of 119 Patients with 1 Year of Follow-up.

Ugradar S, Parunakian E, Malkhasyan E, Chiou CA, Walsh HL, Tolentino J, Wester ST, Freitag SK, Douglas RS. Ugradar S, et al. Among authors: parunakian e. Ophthalmology. 2025 Jan;132(1):92-97. doi: 10.1016/j.ophtha.2024.07.018. Epub 2024 Jul 19. Ophthalmology. 2025. PMID: 39032704

5

Teprotumumab improves light sensitivity in patients with thyroid eye disease.

Parunakian E, Ugradar S, Tolentino J, Malkhasyan E, Raika P, Ghaly J, Bisht C, Douglas RS. Parunakian E, et al. Graefes Arch Clin Exp Ophthalmol. 2024 Sep;262(9):2999-3006. doi: 10.1007/s00417-024-06491-0. Epub 2024 Apr 19. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 38639788

6

A Prospective Study Examining Audiometry Outcomes Following Teprotumumab Treatment for Thyroid Eye Disease.

Douglas RS, Parunakian E, Tolentino J, Malkhasyan E, Geng J, Sherman M, Ugradar S. Douglas RS, et al. Among authors: parunakian e. Thyroid. 2024 Jan;34(1):134-137. doi: 10.1089/thy.2023.0466. Epub 2023 Dec 27. Thyroid. 2024. PMID: 37962269 Free PMC article. No abstract available.

7

Change in lacrimal gland volume and aqueous tear production following treatment with teprotumumab.

Ugradar S, Zimmerman E, Parunakian E, Kang J, Cockerham K, Douglas RS. Ugradar S, et al. Among authors: parunakian e. Clin Exp Ophthalmol. 2023 May-Jun;51(4):339-348. doi: 10.1111/ceo.14208. Epub 2023 Feb 9. Clin Exp Ophthalmol. 2023. PMID: 36723406

8

Changes to Eye Whiteness and Eyelid/Brow Position With Topical Oxymetazoline in Aesthetic Patients.

Ugradar S, Kim JS, Trost N, Parunakian E, Zimmerman E, Ameli K, Shoji MK, Lee WW. Ugradar S, et al. Among authors: parunakian e. Aesthet Surg J. 2022 May 18;42(6):582-589. doi: 10.1093/asj/sjab400. Aesthet Surg J. 2022. PMID: 34962512

9

Frailty and Perceived Financial Exploitation: Findings from the Finance, Cognition, and Health in Elders Study.

Axelrod J, Mosqueda L, Weissberger GH, Nguyen AL, Boyle PA, Parunakian E, Han SD. Axelrod J, et al. Among authors: parunakian e. Gerontol Geriatr Med. 2020 Nov 4;6:2333721420971073. doi: 10.1177/2333721420971073. eCollection 2020 Jan-Dec. Gerontol Geriatr Med. 2020. PMID: 33225020 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters